Charles River Laboratories CRL Total debt

Total debt at other companies

Labcorp HoldingsLH

$6.76B+11.8%

Rapid Micro BiosystemsRPID

$23.76M+301%

Sotera HealthSHC

$2.27B-3.5%

Ginkgo BioworksDNA

$404.11M-5.8%

Fortrea Holdings Inc.FTRE

$1.12B-10.0%

RevvityRVTY

$3.94B+17.8%

FAQ

What is Charles River Laboratories's total debt?

Charles River Laboratories (CRL) reported total debt of $3.04B in Q2 2026.

How has Charles River Laboratories's total debt changed year-over-year?

Charles River Laboratories's total debt increased by 8.1% year-over-year, from $2.81B to $3.04B.

What is the long-term trend for Charles River Laboratories's total debt?

Over 5 years (2020 to 2025), Charles River Laboratories's total debt has grown at a 4.0% compound annual growth rate (CAGR), from $2.19B to $2.66B.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.